Vertex Pharmaceuticals trades at $500.94 and has moved in lockstep with the market. Its shares have returned 5.5% over the ...
Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine ... adults with moderate-to-severe acute pain - for example, after trauma or surgery - and works by blocking ...
Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.
Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results